Name: VLG's Re-invigorating sales in China
Uploaded: 2022-01-13T10:23:55.512249+00:00
Duration: 2031 s
Channel: Vox Markets
Description: VLG's Re-invigorating sales in China

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/003/270/003270/video_2go4T1b.mp4#t=655

Vox Markets

VLG's Re-invigorating sales in China

Overview of product portfolio

Attractions of the OTC consumer healthcare sector

VLG’s key USPs

VLG's Integration of BBI Healthcare & Helsinn acquisitions

VLG's Distributor/retailer destocking in 2021

VLG's Update on Dentyl mouthwash research wrt possible covid protection

VLG's M&A ambitions

VLG's Initial outlook for 2022

VLG's Future newsflow

Venture Life Timestamps

Overview of product portfolio. Start
Attractions of the OTC consumer healthcare sector. 02:10
VLG’s key USPs. 04:20
Integration of BBI Healthcare & Helsinn acquisitions. 07:25
US opportunity. 09:45
Re-invigorating sales in China. 10:55
Distributor/retailer destocking in 2021. 13:45
Managing recent supply chain disruptions. 15:35
Update on Dentyl mouthwash research wrt possible covid protection. 17:55
Product development strategy. 20:30
M&A ambitions. 22:35
Net debt & funding capacity. 26:05
Initial outlook for 2022. 29:20
Board’s longer term targets. 30:45
Future newsflow. 33:00

Venture Life TimestampsOverview of product portfolio. Start Attractions of the OTC consumer healthcare sector. 02:10 VLG’s key USPs. 04:20 Integration of BBI Healthcare &amp; Helsinn acquisitions. 07:25 US opportunity. 09:45 Re-invigorating sales in China. 10:55 Distributor/retailer destocking in 2021. 13:45 Managing recent supply chain disruptions. 15:35 Update on Dentyl mouthwash research wrt possible covid protection. 17:55 Product development strategy. 20:30 M&amp;A ambitions. 22:35 Net debt &amp; funding capacity. 26:05 Initial outlook for 2022. 29:20 Board’s longer term targets. 30:45 Future newsflow. 33:00

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/003/270/003270/video_2go4T1b.mp4